Twist Bioscience secures $50m to advance DNA Synthesis Platform – OutSourcing-Pharma.com
OutSourcing-Pharma.com |
Twist Bioscience secures $50m to advance DNA Synthesis Platform
OutSourcing-Pharma.com “We have used our proprietary DNA synthesis platform, which delivers precision at a scale previously not available, to develop a portfolio of diverse products for two large market opportunities – the synthetic biology market through our gene and oligo … |
